124 related articles for article (PubMed ID: 30774013)
41. A prospective randomized antiplatelet trial of cilostazol versus clopidogrel in patients with bare metal stent.
Chen YD; Lu YL; Jin ZN; Yuan F; Lü SZ
Chin Med J (Engl); 2006 Mar; 119(5):360-6. PubMed ID: 16542577
[TBL] [Abstract][Full Text] [Related]
42. Long term outcome and predictors of ischemic stroke recurrence in adult moyamoya disease.
Noh HJ; Kim SJ; Kim JS; Hong SC; Kim KH; Jun P; Bang OY; Chung CS; Lee KH; Lee KH; Kim GM
J Neurol Sci; 2015 Dec; 359(1-2):381-8. PubMed ID: 26671146
[TBL] [Abstract][Full Text] [Related]
43. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
[TBL] [Abstract][Full Text] [Related]
44. Clinical Features, Surgical Treatment, and Long-Term Outcome in Elderly Patients with Moyamoya Disease.
Ge P; Zhang Q; Ye X; Liu X; Deng X; Wang R; Zhang Y; Zhang D; Zhao J
World Neurosurg; 2017 Apr; 100():459-466. PubMed ID: 28132922
[TBL] [Abstract][Full Text] [Related]
45. Stent thrombosis associated with drug eluting stents on addition of cilostazol to the standard dual antiplatelet therapy following percutaneous coronary intervention: a systematic review and meta-analysis of published randomized controlled trials.
Huang F
BMC Pharmacol Toxicol; 2018 Jun; 19(1):31. PubMed ID: 29914573
[TBL] [Abstract][Full Text] [Related]
46. Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis.
Kwon SU; Hong KS; Kang DW; Park JM; Lee JH; Cho YJ; Yu KH; Koo JS; Wong KS; Lee SH; Lee KB; Kim DE; Jeong SW; Bae HJ; Lee BC; Han MK; Rha JH; Kim HY; Mok VC; Lee YS; Kim GM; Suwanwela NC; Yun SC; Nah HW; Kim JS
Stroke; 2011 Oct; 42(10):2883-90. PubMed ID: 21799173
[TBL] [Abstract][Full Text] [Related]
47. Comparison of 7.0- and 3.0-T MRI and MRA in ischemic-type moyamoya disease: preliminary experience.
Deng X; Zhang Z; Zhang Y; Zhang D; Wang R; Ye X; Xu L; Wang B; Wang K; Zhao J
J Neurosurg; 2016 Jun; 124(6):1716-25. PubMed ID: 26544772
[TBL] [Abstract][Full Text] [Related]
48. Prehospital antiplatelet use and functional status on admission of patients with non-haemorrhagic moyamoya disease: a nationwide retrospective cohort study (J-ASPECT study).
Onozuka D; Hagihara A; Nishimura K; Kada A; Nakagawara J; Ogasawara K; Ono J; Shiokawa Y; Aruga T; Miyachi S; Nagata I; Toyoda K; Matsuda S; Suzuki A; Kataoka H; Nakamura F; Kamitani S; Nishimura A; Kurogi R; Sayama T; Iihara K;
BMJ Open; 2016 Mar; 6(3):e009942. PubMed ID: 27008684
[TBL] [Abstract][Full Text] [Related]
49. Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.
Toyoda K; Uchiyama S; Hoshino H; Kimura K; Origasa H; Naritomi H; Minematsu K; Yamaguchi T;
Int J Stroke; 2015 Feb; 10(2):253-8. PubMed ID: 25487817
[TBL] [Abstract][Full Text] [Related]
50. Neurocognitive impairment in adults with moyamoya disease without stroke.
Karzmark P; Zeifert PD; Bell-Stephens TE; Steinberg GK; Dorfman LJ
Neurosurgery; 2012 Mar; 70(3):634-8. PubMed ID: 21849919
[TBL] [Abstract][Full Text] [Related]
51. [The effects of post coronary stenting triple antiplatelet therapies on platelet functions].
Han YL; Su QF; Li Y; Kang J; Yan CH; Wang SL
Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):635-8. PubMed ID: 17074146
[TBL] [Abstract][Full Text] [Related]
52. A single case report of Moyamoya disease presenting in a psychiatric setting.
Schwarz LR; Thurstin AH; Levine LA
Appl Neuropsychol; 2010 Jan; 17(1):73-7. PubMed ID: 20146125
[TBL] [Abstract][Full Text] [Related]
53. Differential impact of cilostazol on restenosis according to implanted stent type (from a pooled analysis of three DECLARE randomized trials).
Lee SW; Ahn JM; Han S; Park GM; Cho YR; Lee WS; Jang JY; Kwon CH; Lee JY; Kim WJ; Kang SJ; Kim YH; Lee CW; Kim JJ; Park SW; Park SJ
Am J Cardiol; 2013 Nov; 112(9):1328-34. PubMed ID: 23890573
[TBL] [Abstract][Full Text] [Related]
54. Ultra-Early Combination Antiplatelet Therapy with Cilostazol for the Prevention of Branch Atheromatous Disease: A Multicenter Prospective Study.
Kimura T; Tucker A; Sugimura T; Seki T; Fukuda S; Takeuchi S; Miyata S; Fujita T; Hashizume A; Izumi N; Kawasaki K; Katsuno M; Hashimoto M; Sako K
Cerebrovasc Dis Extra; 2016; 6(3):84-95. PubMed ID: 27728903
[TBL] [Abstract][Full Text] [Related]
55. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
[TBL] [Abstract][Full Text] [Related]
56. Platelet reactivity in patients with chronic kidney disease receiving adjunctive cilostazol compared with a high-maintenance dose of clopidogrel: results of the effect of platelet inhibition according to clopidogrel dose in patients with chronic kidney disease (PIANO-2 CKD) randomized study.
Woo JS; Kim W; Lee SR; Jung KH; Kim WS; Lew JH; Lee TW; Lim CK
Am Heart J; 2011 Dec; 162(6):1018-25. PubMed ID: 22137075
[TBL] [Abstract][Full Text] [Related]
57. Pharmacodynamic interaction studies of Ginkgo biloba with cilostazol and clopidogrel in healthy human subjects.
Aruna D; Naidu MU
Br J Clin Pharmacol; 2007 Mar; 63(3):333-8. PubMed ID: 17010102
[TBL] [Abstract][Full Text] [Related]
58. Neurocognitive profiles of children with moyamoya disease before and after surgical intervention.
Lee JY; Phi JH; Wang KC; Cho BK; Shin MS; Kim SK
Cerebrovasc Dis; 2011; 31(3):230-7. PubMed ID: 21178347
[TBL] [Abstract][Full Text] [Related]
59. [Interims analysis of a prospective observational study on the use of cilostazol (Pletal®) in daily clinical vascularsurgical practice].
Meyer F; Graf D; Weber M; Panteli B; Adolf D; Halloul Z
Zentralbl Chir; 2011 Oct; 136(5):436-43. PubMed ID: 22009542
[TBL] [Abstract][Full Text] [Related]
60. Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study.
Uchino H; Kuroda S; Hirata K; Shiga T; Houkin K; Tamaki N
Stroke; 2012 Oct; 43(10):2610-6. PubMed ID: 22871684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
